Categories: News

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Recent Posts

GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals

Following the formal safety review of Cohort 1, no safety or tolerability issues were observed,…

2 hours ago

Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer

Seasoned biopharma executive brings more than twenty years of business development, strategy, and operational expertise…

2 hours ago

Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes 

DENVER, May 19, 2025 (GLOBE NEWSWIRE) -- Porch Light Health (PLH) has partnered with CHESS…

2 hours ago

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a…

2 hours ago